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ABSTRACT
Type 2 diabetes (T2DM), one of the most prevalent chronic diseases, affects the glucose metabolism of
the human body, which decreases the quantity of life and brings a heavy burden on social medical care.
Patients with T2DM are more likely to suffer bone fragility fracture as diabetes affects bone mineral
density (BMD). However, the discovery of the determinant factors of BMD in a medical way is
expensive and time-consuming. In this paper, we propose a novel algorithm, Prior-Knowledge-driven
local Causal structure Learning (PKCL), to discover the underlying causal mechanism between BMD
and its factors from the clinical data. Since there exist limited data but redundant prior knowledge for
medicine, PKCL adequately utilize the prior knowledge to mine the local causal structure for the target
relationship. Combining the medical prior knowledge with the discovered causal relationships, PKCL
can achieve more reliable results without long-standing medical statistical experiments. Extensive
experiments are conducted on a newly provided clinical data set. The experimental study of PKCL
on the data is proved to highly corresponding with existing medical knowledge, which demonstrates
the superiority and effectiveness of PKCL. To illustrate the importance of prior knowledge, the result
of the algorithm without prior knowledge is also investigated.
Keywords Casual mechanism · Prior knowledge · Diabetes mellitus · Bone mineral density · Osteoporosis
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1 Introduction
Diabetes mellitus is one of the most common chronic diseases featured by high levels of blood glucose and type 2
diabetes mellitus (T2DM) is the most frequent subtype of diabetes mellitus. T2DM and its complications cause a
variety of health problems and they bring heavy economic burdens to individuals worldwide [1]. Osteoporosis is a
common skeletal system disease characterized by decreased bone density and normal bone microstructure deterioration
predisposing to an increased risk of bone fracture [2]. Osteoporosis leads to a decrease in physical function and the
impairment of quality of life. Moreover, bone fracture due to osteoporosis causes increased disability rate, mortality,
and a great economic burden on family and society [3].
Measurement of bone mineral density by dual X-ray absorptiometry (DXA) is the most commonly used approach to
diagnose osteoporosis [4]. Decreased BMD reflects the reduction in bone strength that is closely linked to increased
bone fracture risk. Osteoporosis-related bone fracture frequently occurs in patients with T2DM [2,5]. Notably, although
patients with T2DM have higher risks of osteoporosis-related bone fracture than those in non-diabetic individuals, the
BMD is not necessarily identical [6, 7]. As suggested in a recent meta-analysis by Vestergaard, BMD even increases in
patients with T2DM compared with non-diabetic individuals [8].
Many factors affect BMD in diabetes conditions. The traditional large longitudinal prospective studies are helpful to
unravel determinant factors of BMD in T2DM. However, these kinds of studies are very expensive in terms of cost and
time that they are difficult to reach the conclusion within a short time. In addition, the studies on the determinants of
BMD in T2DM need to carry out complicated data analyses and data processing due to the complexity and complications
of T2DM. Existing methods to find the relationship between risk factors and BMD mostly rely on experts’ knowledge
and artificial analysis of clinical data, which is time-consuming and cost-effective. Furthermore, they cannot identify
the underlying causal mechanism between risk factors and BMD in T2DM.
To automatically identify the risk factors of BMD and discover the underlying casual mechanism among them, intelligent
algorithms should be developed. Traditionally, Bayesian networks (BN) structure learning algorithms can learn the
casual mechanism from the data. However, in the medical field, the number of clinical samples are not enough for
a BN structure learning algorithm to discover the real underlying causal mechanism. Moreover, as BMD is affected
by numerous factors, traditional BN structure learning algorithms can not be applied to such a large scale of factors.
Considering that lots of existing medical knowledge are not exploited, this paper proposes a new BN structure learning
algorithm (PKCL), which can learn the underlying causal mechanism between BMD and it’s factors, meanwhile,
incorporating rich existing prior knowledge. With the advantage of incorporating prior knowledge when learning the
BN structure, some of the parameters of the model are determined by the prior knowledge. Thus, PKCL can deal with
the case of large number of factors. Benefiting from prior knowledge, PKCL provides insight into complicated diseases
and offer useful information to clinical experiment. Our contributions are summarized into the following three aspects:
1. Aiming to the clinical data with scarce samples but abundant prior knowledge, a new framework is present to
learn a more accurate model.
2. A structure learning algorithm, PKCL, is proposed to utilize the prior knowledge as well as the causal
information to detect the causal relationships in clinical data.
3. We conclude the prior knowledge of experts about BMD and its risk factors. Conditioned on that, we discover
the underlying causal mechanism between BMD and risk factors.
2 Related Work
It is accepted that patients with T2DM have a higher risk of osteoporosis-related bone fracture than those without
diabetes [5, 9, 10]. Measurement of BMD is used to diagnosing osteoporosis as the golden standard. Nevertheless,
whether the BMD decreases in T2DM is paradoxical according to current clinical studies.
A number of factors affect the BMD in diabetes conditions, such as sex, body mass index (BMI), insulin, and glucose.
The prevalence of higher BMD in T2DM is similar in men and women across racial and ethnic groups including Mexican
American, white, and black people [11–13]. BMI is strongly associated with BMD in T2DM and might explain, in part,
higher BMD in T2DM compared with non-diabetic individuals [14]. Insulin resistance and hyperinsulinemia, which
are characteristics of T2DM, have effects on bone metabolism. High levels of circulating insulin may contribute to
high BMD and there are evidences in preclinical models that altered insulin levels and insulin resistance affect bone
remodeling via direct effects on osteoblasts, osteoclasts, and osteocytes, all of which express insulin receptors [15].
Hyperglycemia is associated with the accumulation of advanced glycation end-products (AGEs) in the bone matrix, and
AGEs inhibit bone formation, an effect mediated at least in part by increased osteocyte sclerostin production [16, 17].
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Given the determinants of BMD is complicated, the derivation of causality will contribute to elucidate the cause of bone
mineral density in T2DM, which is beneficial to prevent and treat osteoporosis-related bone fracture in T2DM.
However, the current work about selecting the most relative risk factors is rarely studied. The existing approaches
are mainly depended on the analysis and experience of the experts, which are not cost-effective and time-efficient. In
addition, they can’t analyze the risk factors of a complicated disease from a data aspect.
In recent studies, feature selection (FS) has been applied to several tasks including classification, regression, and
clustering. A number of FS methods [18–21], which exploit different criteria to select the most informative features,
have been proposed in the literature. They can roughly be divided into three classes: filter, wrapper, and embedding
methods [22]. However, these three classes can not discover the underlying causal relationship between features and
targets. Moreover, their FS criteria lack a theoretical proof of the optimality. The Markov Blanket (MB) algorithms are
showed to have a superior performance over the traditional FS algorithm, as the MB is proved to be the optimal feature
subset [23–25]. And MB algorithms can discover the underlying causal mechanisms of the selected features utilizing
causal feature selection and causal discovery.
Generally, MB discovery can be grouped into two main types: nontopology-based and topology-based. Nontopology-
based MB algorithms exploit independent tests between feature variables and target variables to discover the MB
heuristically. Koller-Sahami (KS) [26] first proposed an approximate algorithm to find the MB, which minimizes the
cross-entropy loss by pruning out some redundant variables in a backward way. Due to the unsoundness of KS, lots
of nontopology-based algorithms are proposed to improve on it. The Growth and Shrink algorithm (GS) [27] first
tests and adds variables, which are sorted by the mutual information with the target variables, into the MB set in the
growth stage. Then the shrinking stage eliminates false-negative nodes from the previous MB sets. Based on GS, The
increment associated MB algorithm (IAMB) [28] improves the performance of GS by resorting the variables each time
the MB set changes. After that, numerous variants of IAMB have been proposed including IAMBnPC, inter-IAMB,
and KIAMB [29]. However, with the size of variables growth, the need for samples grows exponentially. If the sample
data isn’t enough, the performance of IAMB and its variants will degrade.
As the limited data in real-world applications, topology-based methods are proposed to solve the data efficiency while
keeping a reasonable time cost. Min-max MB (MMMB) [30] discovers the MB set by finding the parent-and-children
set first and then finding the spouses, in which way the sample size only relies on the Directed Acyclic Graph (DAG)
structure rather than the size of variables. Although MMMB is later proved to be unsound [31], the two steps of
discovering the MB set are the foundation of the following methods. HITON-MB [31] inherits the framework of
MMMB and interweaving the two steps to exclude the false positives from parents and children (PC) sets as early
as possible, which can decrease the number of independent tests (ITs) needed later. However, Both MMMB and
HITON-MB are unsound due to the incorrectness of PC discovery. Parent children-based MB algorithm (PCMB) [29],
the first sound topology-based MB algorithm, which utilizes a double check strategy to fix the errors in PC discovery, is
then introduced by Pena et. al. After that, Iterative parent children-based MB (IPCMB) algorithm [32] are proposed
based on PCMB and discover the PC set more efficiently. Recently, Simultaneous MB algorithm (STMB) [33] is
developed to improve the time efficiency of MB algorithms by utilizing the property of coexisting between descendants
and spouses.
Although MB algorithms can discover the underlying causal mechanism between variables and targets, they can’t
recognize the direction of the dependency. By BN structure learning, a DAG over all nodes can be constructed using the
local MB sets. One approach of learning BN structure is constraint-based, which discover the arcs between each node
pairs by conditional independent test (CIs). However, the number of CIs needed growth exponentially with the increase
of the nodes. Moreover, as each CIs is calculated based on the results of another, it will lead to inevitable escalated
errors. Another approach to learning BN structure is score-based.
3 Notation and Definition
Let capital letters denote variables (such as M,N ), lower-case letters (such as m,n) denote the value of random
variables and capital bold italic (such as M ,N ) denote variable sets.
Definition 1 (Bayesian Network [34]) Formally, a Bayesian Network is a triplet < G,P ,U >, which denotes a
joint probability distribution P over a random variable set U and can be represented by a DAG where each node
corresponds to a random variable.
If there is an arc from M to N , which means MN ∈ G, then M is said to be a parent of N and N is a children of M .
In addition, if M is a parent or children of N ,they are said to be neighbors. Node M and N are said to be spouses
of each other if they have a common child and there is no arc between M and N .If there is a directed path from M
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to N in G, then N is a descendant of M . And the descendants and the parents of X is represented as Des(X) and
Pa(X). Further, we use HG(X) and SG(X) to denote the neighbors and the spouse of node X in G.
Definition 2 (Markov Condition [34]) Every node in the BN is independent of its nondescendant nodes, given its
parents. Thus, if a BN < G,P ,U >, according to the definition of Markov Condition, the joint probability P can be
decomposed into the product of a series conditional probabilities:
P (U) =
∏
X∈U
P (X|Pa(X))
Definition 3 (V-Structure [34]) Three nodes M , X , and N are said to be a V-structure if there are two arcs from
M , N to N and M is not adjacent to X .
X is said to be a collider if X has two incoming arcs from M and N , no matter M and N are adjacent or not. On the
condition that M and N are adjacent, we say Y is an unshielded collider for the path from M to N .
Definition 4 (Blocked Path [34]) Any path from node in M to node in N is said to be blocked by a variable set Φ
iff: 1) Φ comprises a head-to-tail (M → X → N ) or tail-to-tail (M ← X → N ) chain, and M ∈N . 2) Φ comprises
a head-to-head (M → X ← N ) chain, where X /∈ Z and any node in Des(X) /∈ Z.
Definition 5 (d-Separation [34]) If all paths from M to N is blocked by Φ, then Φ is said to d-sperate M and N ,
denoted as Dsep(M,N |Z)
Definition 6 (Faithfulness Condition [34]) Given a BN < G,P ,U >, P and G are faithful to each other iff: all
and only the condition probabilities true in P are entailed by G. Formally, for any M,N in U and Z ⊆ U − {M,N},
M ⊥ N |Z in P iff Dsep(M,N |Z) in G
Definition 7 (Markov Blanket [34]) Formally, given the MB of a target node T , denoted as MB(T ), T is indepen-
dent of U \MB(T ).
Definition 8 (PCMasking [35]) Let PC(X) denotes the PC set of variable X. PC1 and PC2 denote two subsets of
PC(X) and PC1 ∩ PC2 = ∅. PC1 and PC2 are PCMaksing for variable X if
X ⊥ PC1|PC2, X ⊥ PC2|PC1
PC(X) and PC1 are called MaskingPCs.
Theorem 1 (MB Uniqueness [34]) Given a BN< G,P ,U >, if P and G are faithful to each other, then
MB(T ), T ∈ U , is unique and is the node set of neighbors H(T ) and spouses S(T ).In addition, H(T ) is also
unique.
4 Methods
In this section, we propose a BN structure learning algorithm driven by prior knowledge. Section V-A demonstrates the
structure of PKCL and Section V-B, Section V-C demonstrate two-stage of it.
4.1 Overview
In real-world applications, the number of samples is limited while the number of features is numerous. If directly
develop a structure learning (SL) algorithm in the limited data set, the output DAG can hardly reflect the real underlying
casual mechanism among variables. Meanwhile, the existing SL algorithms ignore the significance of experts’ prior
knowledge, which leads to the poor performance of the algorithms. Motivated to incorporate the SL algorithm with the
experts’ prior knowledge, we propose an SL algorithm, which learns the BN structure and adds the prior knowledge
simultaneously to build a global structure.
PKCL algorithm works in two phases: the local stage and the global stage. The pseudo-code of PKCL algorithm is
denoted as Algorithm 1. In the local stage (lines 1-4 of Algorithm 1), PKCL first discovers the neighbors of the target
variables and then detects the MaskingPCs to eliminate the effect of them. After that, it finds the spouse of target
variables utilizing the neighbors set. Thus, the skeleton of BN is constructed and the detail of this stage is discussed in
Section V-B.
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Table 1: STATISTICAL INFORMATION OF THE CLINICAL DATA SET. SIX KINDS OF BMDS ARE NAME OF
BMD1 TO BMD6
No. Features Type Description No. Features Type Description
1 Duration Numeric Duration of disease 18 AST Numeric Aspartate aminotransferase
2 Sex Boolean 19 GGT Numeric Gamma glutamyltransferase
3 Age Numeric 20 20-OH-VD Numeric 25-hydroxyvitamin vitaminD
4 Height Numeric 21 UALB/Ucr Numeric Urine albumin creatinine ratio
5 Weight Numeric 22 BMD1 Numeric Lumbar spines (L1¨CL4)
6 BMI Numeric BMI=weight(kg)/height(m)2 23 BMD2 Numeric Distal radius
7 FPG Numeric Fasting plasma glucose 24 BMD3 Numeric Femoral neck
8 HbAlc Numeric Glycated hemoglobin 25 BMD4 Numeric Wards triangle
9 Cr Numeric Serum creatinine 26 BMD5 Numeric Greater trochanter
10 UA Numeric Serum uric acid 27 BMD6 Numeric Total hip
11 Ca Numeric Calcium 28 OC Numeric Osteocalcin
12 P Numeric Phosphorus 29 CTX Numeric C-terminal telopeptide of type I collagen
13 ALP Numeric Alkaline phosphatase 30 PINP Numeric N-terminal propeptide of type 1 procollagen
14 TG Numeric Triglyceride 31 SBP Numeric Systolic blood pressure
15 TC Numeric Total cholesterol 32 DBP Numeric Diastolic blood pressure
16 Alb Numeric Albumin 33 LDL-C Numeric low-density lipoprotein cholesterol
17 ALT Numeric Alanine aminotransferase 34 HDL-C Numeric High-density lipoprotein cholesterol
Algorithm 1 PKCL
Input: Data D on node set N , Target node set T , Prior rule set R
Output: Directed acyclic graph G
1: {Local stage}
2: for all T ∈ T do
3: MB(T )← CCMB(D,T )
4: end for
5: {Global stage}
6: G, f lag ←FINDCOLLIDER(D,MB,R)
7: if not flag then
8: G←SCORESEARCH(D,MB,R)
9: end if
10: return G
In the global stage (lines 6-9 of Algorithm 1), PKCL leverages the MB sets learned in the local stage to learn the
global BN structure, in which prior knowledge is incorporated to guide the global learning phase. Specifically, it learns
the casual direction between feature variables and target variables by combining the constraint-based method and
score-based method. What’s more, in the learning phase, it automatically adds casual direction according to the prior
knowledge. The detail of this stage is discussed in Section V-C.
4.2 The Local Stage
In this stage, we present a cross-check and complement MB discovery (CCMB) [35]. CCMB is a topology-based
MB discovery algorithm, different from other previews algorithm, it discovers the MB set of a node while repair the
incorrect conditional independent (CI) tests via eliminating the PCMasking phenomenon.
The pseudo-code of CCMB is represented in algorithm 2. Specifically, it works in the following three steps.
Step1 (algorithm 3): Discover the neighbors of node T . The pseudo-code of this step is represented in algorithm 3. For
each target node T in T , the algorithm works in three phases: First, find the potential neighbors set H(T ) of T , then
score and rank the potential neighbors to choose the best one from H(T ), and finally prune out the false variables.
Step2 (lines 4-11 of algorithm 2): Prune out MaskingPCs of node T . Compared to other MB algorithms, this step
is the key point that makes CCMB outperform them. CCMB exploits a cross-check method(lines 4-8) to discover
the MaskingPCs and appends them into PCMasking table PCM in the format of [T,X], where T denotes the target
variable and X denotes the cross-checked variable. Specifically, if T is the neighbor of X while X is not the neighbor
of T , the cross-check method will take X and T as MaskingPCs because of the asymmetry between them.
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Algorithm 2 CCMB(D,T)
Input: Data D on node set N , Target node T
Output: The Markov boundary of T
1: {Step 1: Find the Neighbors}
2: H(T )← FINDNEIGHBORS(D,T )
3: {Step 2: Eliminate PCMasking phenomenon}
4: for all X ∈N − {T} do
5: if T ∈ FINDNEIGHBORS(D,X) and X /∈H(T ) then
6: PCM(V )← PCM(V ) ∪ {[T,X]}
7: end if
8: end for
9: for all [T,X] ∈ PCM(T ) do
10: H(T ) =H(T ) ∪ {X}
11: end for
12: {Step 3: Find the spouse set}
13: S(T )← FINDSPOUSE(D,T,H(T ))
14: return MB(T )←H(T ) ∪ S(T )
Step3 (algorithm 4): Discover the spouses of node T . The pseudo-code of this step is represented in algorithm 4. If Y is
the neighbors of T and X is the neighbor of Y , then find a node subset Z conditioned on which T is independent of X .
4.3 The Global Stage
After the MB sets discovered, local information can be integrated to get the structure of DAG. Traditionally, the next
step is to determine the direction of the edge, and thus, the underlying causal mechanism is learned. However, this way
of learning the DAG is totally depended on the clinical data, which means a lot of knowledge in the medical field are
ignored. Thus, some of the causal relationships that only learned from clinical data in conflict with medical knowledge
and some causal relationship that is already proved in medical literature can not be learned.
PKCL learns the structure of a DAG between nodes via leveraging the MB sets discovered in the local state. Different
from other structure learning method, the learning process of PKCL is routed by the prior knowledge of experts, which
means the PKCL works in a more data-efficient way while maintaining superior performance. Specifically, PKCL first
discovers the colliders to constructed the overall DAG. if there is no collider discovered, we use a heuristic method with
the constraints of MB sets and prior rules to construct the DAG of the underlying BN. Here, the heuristic algorithm we
used is the steepest ascent hill-climbing with a TABU [36] list of the last 100 structures and a stopping criterion of 15
steps without improvement in the maximum score.
5 Experiments
5.1 Data Collection and discretization
In our study, the clinical data of patients with T2DM are collected in the Department of the First Affiliated Hospital
of the University of Science and Technology of China. As some patient samples contain several missing values and
abnormal values, the data set is cleaned and completed during the preprocessing procedure. After that, a clinical data
set of PKCL patient sample are collected, in which each sample has 34 features including anthropometric indexes
of patients, biochemical indexes, lipid profile, and vitamin D levels from the assay of patients¡¯ blood samples. And
the 34 features are labeled from 1 to 34. The description of them is shown in Table 1. The prior knowledge used in
the experiment is that feature 3, 5, 6, 7, and 8 are the causes of six BMDs. Before experiments, the data should be
discretized. Here we use a packed toolkit Causal Explorer [37]. The detailed description is added in the appendix.
5.2 Quality analyzation of selected features
The overall experiment comprises two-stage. To demonstrate the superiority of PKCL, each stage of PKCL is analyzed.
In the local stage, four traditional feature selection algorithms and four MB algorithms are also applied to the clinical
data set. To evaluate the quality of selected features, five classifiers are learned based on the selected features of nine
algorithms and the prediction accuracy is computed. In the global stage, to demonstrate that the casual relationship
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Algorithm 3 FindNeighbors(D,T ):
Input: Data D on node set N, Target node T
Output: The PC subset
1: { Step 1: Find the potential neighbors}
2: for all T ∈ T do
3: H(T )← ∅, PH(T )←N \ T
4: while PH(T ) 6= ∅ do
5: for all X ∈ PH(T ) do
6: Sep[X] = argminZ⊆H dep(T,X|Z)
7: if T ⊥ X|Sep[X] then
8: PH(T )← PH(T )− {X}
9: end if
10: end for
11: for all X,Y ∈ PH(T ) do
12: if X 6⊥ Y and T ⊥ X|Y then
13: PH(T )← PH(T )− {X}
14: end if
15: end for
16: for all X ∈ PH(T ) do
17: Score[X] = dep(T,X|Sep[X])
18: end for
19: Y = argmaxX∈CanPC Score[X]
20: H(T )←H(T ) ∪ {Y }
21: PH(T )← PH(T )− {Y }
22: for all X ∈H(T ) do
23: if ∃Z ⊆H(T )− {X}s.t.T ⊥ X|Z then
24: H(T )←H(T )− {X}
25: end if
26: end for
27: end while
28: end for
29: return The Neighbors set of nodes in T H
Algorithm 4 FindSpouse(D,T,H):
Input: Data D on node set N, Target node T, MB sets
Output: The spouse set of T
1: for all Y ∈H(T ) do
2: for all X ∈H(Y ) do
3: if X /∈H(T ) then
4: find Zs.t.T ⊥ X|Z and T,X /∈ Z
5: if T 6⊥ X|Z ∪ {Y } then
6: S(T )← S(T ) ∪ {X}
7: end if
8: end if
9: end for
10: end for
11: return S(T)
learned after incorporated prior knowledge is more reasonable than the causal relationship learned without prior
knowledge, not only the DAG with prior knowledge is learned, but also the DAG without prior knowledge are learned.
At first, we randomly select 400 samples from the dataset to implement the CCMB algorithm and other four MB
algorithms and four traditional feature selection algorithms, namely IAMB [28], PCMB [29], MBOR, STMB [33],
mRMR, Fisher, FCBF, and RFS. Then, in order to demonstrate the superiority of PKCL, five classifiers, i.e., Support
Vector Machine (SVM), k-Nearest Neighbors(kNN), AdaBoost, Random Forest (RF), and Naive Bayes (NB) are trained
with their selected features. In addition, the classifiers are also trained with the original features to be considered as a
baseline, which can demonstrate that the feature selection algorithms can improve the prediction accuracy of classifiers
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Algorithm 5 FindCollider(D,MB,R):
Input: Data D on node set N , MB sets, Prior rules R
Output: Directed acyclic graph G
1: G← ∅
2: for all X ∈N do
3: for all Y ∈MB(X) do
4: for all Z is the common child of X and Y do
5: if possible without introducing cycles and satisfies prior knowledge R then
6: add XY and YZ to G
7: end if
8: end for
9: end for
10: end for
11: return G
by extracting the informative features. The k is set to 10 in kNN classifier. Lastly, the rest 100 samples are used as
testing data to evaluate the quality of the selected features.
The experimental results on six BMD are listed in Table 2. As Table 2 shows, when the label is BMD1, BMD2 or
BMD5, the five classifiers using the features selected by PKCL achieves the best prediction accuracy. When the label
is BMD3, BMD4 or BMD6, SVM, KNN, Adaboost, and Random Forest also achieves the best prediction accuracy
using the feature selected by PKCL, although Naive Bayes achieves the best prediction using the feature selected
by mRMR, the result is still competitive when using the feature selected by PKCL. Specifically, the five classifiers
achieve 0.9-19.2% improvement of prediction accuracy in comparison to the result of using all features, which brings a
significant improvement. In addition, the selected features are the input of the global stage of PKCL, if the selected
features are more informative, the underlying causal mechanism will be more reasonable.
5.3 Learning the DAG with prior knowledge
To illustrate the significance of prior knowledge, the DAG that not incorporating prior knowledge is also learned. The
overall DAG learned with prior knowledge and the overall DAG learned without prior knowledge are presented in the
appendix. Here only six BMDs concerned are analyzed. Figure 1 is the local casual relationship of six BMDs and
features. Each sub-figure presents the local casual relationships of one BMD, which contains both the local casual
relationships incorporating prior knowledge and not incorporating prior knowledge.
In order to have an insight into the differences between the DAG that incorporating prior knowledge and the DAG
that not incorporating prior knowledge, we first analyze the DAG that incorporating prior knowledge and then analyze
the DAG not incorporating prior knowledge, finally, the superiority of the former and the inaccuracy of the latter are
analyzed in detail.
The DAG incorporating prior knowledge is analyzed as follows. As Figure 1 shows, all BMDs have no effect on any
feature, which means BMDs are the comprehensive effects of some risk factors and BMDs don’t have effects on any
risk factors. In addition, feature 1, 2, 3, 5, 6, 7, 8, 11, 12, 15, 28, 29, 33 are the common causes of all six BMDs, which
means these features have an underlying effect on the decrease of mine density. Feature 9,30 are the causes of BMD1.
Feature 16, 30 are the causes of BMD2. Feature 9, 10, 20, 34 are the causes of BMD3. Feature 16, 17 are the causes of
BMD4. The effect of BMD1 is feature 22. The effects of BMD2 are feature 7, 8, 26. The effect of BMD3 is feature 15.
The effects of BMD4 are feature 6, 23, 25. The effects of BMD5 are feature 25, 32. BMD6 has no effect on any feature.
The DAG not incorporating prior knowledge is analyzed as follows. Feature 1, 2, 3 are the common causes of all six
BMDs. Feature 11, 13, 15, 21, 28, 30, 33, 34 are the causes of BMD1. Feature 4, 10, 11, 12, 14, 15, 16, 18, 19, 20, 25,
28, 29, 30, 32 are the causes of BMD2. Feature 6, 28 are the causes of BMD3. Feature 7, 10, 13, 16, 17, 20, 21, 26, 28,
30 are the causes of BMD4. Feature 4, 8, 10, 21, 23, 30, 31, 33 are the causes of BMD5. Features 12, 19, 20, 30, 32, 34
are the causes of BMD6.
The difference between the DAG incorporating prior knowledge and not incorporating prior knowledge is analyzed as
follows. For BMD1, the arcs from feature 13, 21, 34 to BMD1 and the arc BMD1 from 19 are removed while there are
new arcs added from features 5, 6, 8, 9, 12, 29, 33 to BMD1. The arc from feature BMD3 to feature 15 is removed
while there are new arcs added from features 5, 7, 8, 9, 10, 11, 12, 15, 20, 29, 33, 34 to BMD3. The arcs from feature 7,
10, 13, 20, 21, 26, 30 from BMD4 and arcs from BMD4 to feature 6, 23, 25 are removed while there are new arcs added
from feature 5, 6, 7, 8, 9, 11, 12, 15, 29, 33 to BMD4. The arcs from features 4, 8, 10, 21, 23, 30, 31 to BMD5 and arcs
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Table 2: The prediction accuracy (in %) on the test samples. The best result of each classifier is illustrated in bold. All
denotes no feature selected algorithm is applied.
Lable Classify IAMB PCMB MBOR STMB mRMR Fisher FCBF RFS ALL Ours
BMD1
SVM 55.3 65.283 60.427 63.75 72.354 69.423 67.941 68.014 64.57 76.219
KNN 58.393 69.6 60.646 67.087 74.127 70.086 72.467 69.929 66.522 80.175
Adaboost 55.915 67.009 60.444 64.187 68.64 66.923 68.02 67.546 63.123 72.875
Random Forest 59.013 69.038 60.921 68.167 75.773 74.146 72.909 70.628 63.151 78.903
Naive Bayes 59.475 68.923 60.581 67.396 74.339 68.131 72.458 71.278 65.027 75.242
BMD2
SVM 53.544 63.951 55.388 62.936 69.488 65.762 63.926 63.67 61.005 73.201
KNN 56.633 64.847 58.898 64.916 69.927 65.494 71.202 67.628 62.25 77.015
Adaboost 53.108 64.446 56.529 62.39 64.747 64.319 63.781 63.329 62.322 71.599
Random Forest 54.081 65.209 56.983 63.644 73.259 71.095 71.798 67.62 61.656 77.618
Naive Bayes 56.168 65.689 58.777 64.827 72.044 65.393 68.061 67.106 62.085 73.055
BMD3
SVM 54.093 63.519 57.711 62.894 69.368 67.011 65.427 65.038 62.501 74.378
KNN 56.891 68.333 59.328 65.395 72.031 68.046 71.813 67.889 63.685 78.917
Adaboost 53.4 63.928 57.85 63.386 66.364 65.656 65.904 65.571 61.473 71.084
Random Forest 57.376 67.778 60.181 65.916 72.127 71.206 72.25 69.043 61.777 76.949
Naive Bayes 56.704 66.208 59.913 65.701 73.765 65.993 69.108 68.93 61.975 72.93
BMD4
SVM 53.253 61.409 54.578 59.979 70.107 67.461 61.401 65.376 62.968 70.197
KNN 53.747 67.956 57.149 63.724 73.254 69.152 67.877 64.256 60.841 78.813
Adaboost 54.54 62.053 55.864 61.419 63.851 62.71 65.129 62.369 59.105 67.217
Random Forest 56.345 66.37 60.107 61.976 73.471 70.079 67.521 66.696 59.252 78.304
Naive Bayes 57.193 64.551 55.76 64.231 71.444 64.54 67.782 66.282 60.751 69.344
BMD5
SVM 50.583 61.595 56.123 59.385 66.177 64.351 61.391 64.528 59.907 73.295
KNN 52.876 68.313 59.261 63.652 72.242 67.172 71.41 65.663 63.704 74.675
Adaboost 51.036 65.207 57.615 59.669 67.302 62.788 63.952 61.715 61.853 70.117
Random Forest 53.231 64.202 59.92 65.132 73.453 69.624 68.88 65.835 60.399 75.876
Naive Bayes 53.374 65.446 59.815 64.959 72.456 63.077 68.431 66.953 62.478 73.045
BMD6
SVM 53.711 64.191 57.831 62.89 69.616 65.743 64.496 66.123 62.75 74.558
KNN 56.755 66.571 59.665 65.56 72.618 68.729 71.871 68.614 63.417 78.743
Adaboost 54.615 64.692 57.83 62.673 65.816 65.955 66.14 65.566 62.76 71.893
Random Forest 56.593 66.914 58.654 65.191 73.266 71.568 71.959 68.351 61.332 76.743
Naive Bayes 57.065 66.75 59.95 65.592 73.39 65.815 70.713 70.173 62.404 72.326
from BMD5 to 25, 31 are removed while there are new arcs added from feature 5, 6, 7, 11, 12, 15, 28, 29 to BMD5.
The arcs from feature 12, 19, 20, 30, 32, 34 to BMD6 are removed while there are new arcs from feature 5, 6, 7, 8, 11,
12, 15, 28, 29, 33 to BMD6.
5.4 Discussion
As we analyzed above, PCKL can discover the underlying causal mechanism between BMDs and their related risk
factors. Here some casual relationships that have already been discovered in the clinical field will be discussed, which
can demonstrate the superiority of PKCL. In addition, the new casual mechanism found by PCKL will provide an
insight into the relationship between BMDs and their factors, which may contribute to the prevention and treatment of
diabetes-related osteoporosis.
A report shows that 1 out of 3 women and 1 out of 5 men over 50 years old will experience an osteoporotic fracture at
some point in their life [38]. Patients with T2DM, one of the most common chronic diseases, suffer from an increased
osteoporotic-related bone fracture risk, which places a heavy burden on individuals. BMD is the golden standard for
diagnosing osteoporosis. However, the causal chain involved in BMD and T2DM is not clear.
In elderly diabetic individuals, AGEs may inhibit the phenotypic expression of osteoblast and promote osteoblast
apophasis, thereby contributing to the deficiency in the bone formation [39,40]. AGEs also increases osteoclast-induced
bone resorption. The study by Zhou et al. has indicated that increasing age is a more important risk factor for bone
mineral loss in patients with T2DM than diabetes duration [41]. The report by Wang et al. has indicated that the adverse
changes in the collagen network occur with aging and such changes may lead to the decreased toughness of the bone [42].
Moreover, the porosity of the bone significantly increases with aging and correlates to bone strength and stiffness [42].
Therefore, BMD negatively correlates to aging. After bone mass reaches a peak in the third or fourth decade of life,
vertebral bone mass and density decrease with aging for both females and males [43]. Moreover, AGEs accumulation
occurs in the bone with aging, increasing by 4 to10 fold at the age, of 50 years old [44]. As discussed below, increased
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(a) BMD1 (b) BMD2
(c) BMD3 (d) BMD4
(e) BMD5 (f) BMD6
Figure 1: The causal relationships of six BMDs. Each sub-figure illustrates the local causal relationship of one BMD.
The left of each sub-figure is the local relationships that incorporating prior knowledge and the right is local
relationships that not incorporating prior knowledge. The red circle in the central presents BMD and cyan circle in the
edge presents feature.
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levels of AGEs in bone tissues have been shown to be associated with diminished bone mechanical function and
reduced cortical and trabecular bone strength. Additionally, age-related bone loss is associated with abnormalities
in vitamin D status. Reduced serum levels of active vitamin D metabolites, 25-hydroxylamine-D[25(OH)D] and 1α,
25-(OH)2-D, occur with aging in both sexes [45, 46]. Nutritional vitamin D deficiency may contribute to secondary
hyperparathyroidism and bone loss with aging since decreases in serum 25(OH)D levels correlate inversely with serum
parathyroid hormone levels and positively with BMD [47].
As indicated in this study, hyperglycemia is another important factor determining BMD in patients with T2DM. It could
be explained as follows. Firstly, diabetes has been shown to cause decreased osteopsathyrosis, reduced bone formation,
and enhanced osteoblast apophasis in a bone-loss mouse model [48]. Secondly, hyperglycemia leads to glycosuria,
which results in a loss of calcium. Hypercalciuria presented as a raised glomerular filtration rate, reduces calcium
reabsorption and impairs bone deposition in diabetic rats [49]. Hypercalciuria decreases the level of calcium in the bone,
leading to poor bone quality [50]. Some reports indicate that the hypercalciuria in patients with uncontrolled blood
glucose could stimulate parathyroid hormone secretion, which may contribute to the development of osteopenia [51].
Thirdly, hyperglycemia is known to generate higher concentrations of AGEs in collagen [52]. AGEs have been shown
to be associated with decreased strength in human cadaver femurs [10]. The combination of the accumulation of AGEs
in bone collagen and lower bone turnover may contribute to reduced bone strength for a given BMD in diabetes [53].
AGEs and oxidative stress produced by hyperglycemia may reduce enzymatic beneficial cross-linking, inhibit osteoblast
differentiation, and induce osteoblast apoptosis [50].
Height, weight, sex, and obesity are also factors affecting BMD in T2DM. As a Korean population-based study reported,
sex affects BMD. The difference in BMD distribution at the same skeletal site may be partially explained by distinctive
endocrine and paracone factors between the two sexes [54]. It has been suggested that bone loss in elderly men is
mostly a result of decreased bone formation, whereas bone loss in postmenopausal women is a result of excessive bone
resorption [55]. Sex hormones may account for this difference. Estrogen rapidly decreases in postmenopausal women.
An accelerated phase of predominantly cancellous bone loss initiated by menopause is the result of the loss of the direct
restraining effect of estrogen on bone turnover [56]. Estrogen acts on high-affinity estrogen receptors in osteoblast and
osteoclasis to restrain bone turnover [57]. Estrogen also regulates the production, by osteoblastic and marrow stromal
cells, of cytokines involved in bone remodeling, such as interleukin (IL)-1, IL-6, tumor necrosis factor-α, prostaglandin
E2, transforming growth factor-β, eta, and osteoprotegerin [57,58]. The net result of the loss of direct action of estrogen
is a marked increase in bone resorption that is not accompanied by an adequate increase in bone formation, resulting in
bone loss. The accelerated phase of bone loss in women is due to direct skeletal consequences of rapid reduction in
serum estrogen following the menopause.
High body weight and obesity have been shown to be associated with high BMD in many observational studies [59].
Obesity may lead to increased BMD because it is associated with higher 17 δ -estradiol levels and higher mechanical
load, which may protect bone [60, 61]. Visceral fat accumulation is associated with higher levels of pro-inflammatory
cytokinesis, which may up-regulate receptor activators of nuclear ligand, leading to increased bone resorption and
therefore decreased BMD [62–64].
Some studies have shown that weight loss, both intentional and unintentional, is associated with the decreases in BMD.
The study by Geoffroy et al. has shown that more than 70% of patients have clinically significant BMD loss at 12
months after bariatrics surgery [65]. This loss of bone density was observed at the femoral neck and femur [65]. Then
the significant reduction in BMD was related by bivariate analysis to the extent of reduction in BMI, weight loss, and to
loss of fat and lean mass [65]. A recent study in elderly women has identified risk factors for hip BMD loss over four
years and concluded that women who gain weight show attenuated BMD loss at the trochanter, femoral neck, and total
hip [66].
6 Conclusion
In this paper, we propose a new BN algorithm (PKCL) that can find the underlying causal mechanism between six
BDMs and their related factors. PKCL includes two stages: the local stage that discovers the local MB sets and the
global stage that learns the direction of casual-effect relationship.
In addition, to demonstrate the superiority and effectiveness of PCKL, a clinical data set that concludes the clinical
indexes of the patient with T2DM was collected and preprocessed. Experiments on this dataset shows that PKCL
can discover the casual relationships that have already been discovered in clinical literature. What’s more, PKCL can
discover new casual relationships to assist clinical researchers in carrying out new experiments, which can save a lot of
time and money. Different from other BN algorithm, PCKL incorporates rich prior knowledge, which means it can
achieve good performance even when the dataset is small while the feature is numerous. What’ more, PCKL is not
limited in the clinical literature but can be adjusted into any domain if incorporated with prior knowledge. The future
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work on this subject will employ other probabilistic models [67, 68] and learning in the model space [69, 70] for this
kind of problems.
Figure 2: The DAG before incorporating prior knowledge
Figure 3: The DAG after incorporating prior knowledge
7 Appendix
7.1 The process of discretization
The discretization method that works as follows:
1. Data is normalized so that each variable has mean 0 and standard deviation 1
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2. After normalization, association of each variable with the response variable is computed using either Wilcoxon
rank sum test (for binary response variable) or Kruskal–Wallis non-parametric ANOVA (for multicategory
response variable) at 0.05 alpha level [71].
3. If a variable is not significantly associated with the response variable, it is discretized as follows:
• 0 for values less than -1 standard deviation
• 1 for values between -1 and 1 standard deviation
• 2 for values greater than 1 standard deviation
4. If a variable is significantly associated with the response variable, it is discretized using sliding threshold
(into binary) or using sliding window (into ternary). The discretization threshold(s) is determined by the
Chi-squared test to maximize association with the response variable [72].
The discretization procedure can be instructed to compute necessary statistics only using training samples of the data to
ensure unbiased estimation of error metrics on the testing data.
7.2 Two pictures of the overall DAG
Figure 2 is the learned DAG that not incorporating prior knowledge. Figure 3 is the learned DAG that incorporating
prior knowledge. The circle represents the features and the arc represents the causal relationship. The numbers in the
circle denote the features and Table 1 lists the corresponding relationships.
7.3 Abbreviations and its descriptions
Table 3 is the abbreviations appear in the paper and its descriptions
Table 3: Abbreviations and its descriptions
Abbreviations Descriptions
AGEs advanced glycation end-products
BMD bone mineral density
BN Bayesian networks
CCMB cross-check and complement MB discovery
CIs conditional independent tests
DAG Directed Acyclic Graph
DXA X-ray absorptiometry
FS feature selection
GS The Growth and Shrink algorithm
IAMB The increment associated MB algorithm
IPCMB Iterative parent children-based MB
ITs independent tests
kNN k-Nearest Neighbors
KS Koller-Sahami
MB The Markov Blanket
MMMB Min-max MB
NB Naive Bayes
PC parents and children
PCMB Parent children-based MB algorithm
PKCL Prior-Knowledge-driven local Causal structure Learning
RF Random Forest
SVM Support Vector Machine
STMB Simultaneous MB algorithm
SL structure learning
T2DM Type 2 diabetes
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